<DOC>
	<DOCNO>NCT01919853</DOCNO>
	<brief_summary>The purpose study compare effect Mindfulness-Based Stress Reduction ( MBSR ) attention control psycho-educational support group treat cancer-related fatigue ( CRF ) early-stage ( 0-III ) post-treatment cancer survivor clinically-significant CRF . The study collect , store , later analyze blood urine sample several biomarkers may link persistent CRF cancer survivor .</brief_summary>
	<brief_title>Treatment Persistently Fatigued Cancer Survivors : A Randomized Controlled Trial With Biomarker Response</brief_title>
	<detailed_description>This randomize , attention control clinical trial compare MBSR support education biobehavioral outcome early-stage ( 0-III ) post-treatment cancer survivor clinically-significant CRF . The study use quantitative qualitative method evaluate follow : Primary Aim 1 : Determine effect size estimate MBSR compare attention control reduce fatigue interference severity several cancer-related symptom immediately post-intervention 6-month follow-up . Exploratory Aim 1 : To identify potential moderator intervention effect breast cancer survivor ( BCS ) colorectal cancer survivor ( CRCS ) , demographic , clinical/disease characteristic , personality trait , baseline mindfulness level . Exploratory Aim 2 : To compare level number anti- pro-inflammatory protein present blood urine MBSR attention control group immediately post-intervention 6-month follow-up , fatigue non-fatigued breast cancer survivor baseline .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Inclusion Criteria breast cancer participant : age 18 old live Indianapolis region establish firsttime diagnosis nonmetastatic ( stage 0III ) breast cancer treat chemotherapy and/or radiation therapy good general health ( selfreport ) clinicallysignificant CRF ( Fatigue Symptom Inventory [ FSI severity composite ≥ 4 ] ) persist previous 8 week longer . Inclusion Criteria colorectal cancer participant : age 18 old live Indianapolis region establish diagnosis colorectal cancer ( stage ) treatment currently previously chemotherapy and/or radiation therapy clinicallysignificant CRF ( Fatigue Symptom Inventory [ FSI severity composite ≥ 4 ) persist previous 8 week longer . Exclusion Criteria breast cancer participant : cancer treatment ( chemotherapy , biologic response modifier , radiation therapy , surgery ) prior 3 month &gt; 5 year ago ( endocrine therapy breast cancer allow ) enrollment hospice care severe depression ( PHQ8 ≥ 20 ) past participation mindfulness meditation class and/or established/ongoing meditation practice Exclusion Criteria colorectal cancer participant : enrollment hospice care severe depression ( PHQ8 ≥ 20 ) past participation mindfulness meditation class and/or established/ongoing meditation practice A nonfatigued group posttreatment BCS also enrol order compare baseline level biomarkers selfreported psychosocial measure fatigue nonfatigued BCS . Inclusion criterion nonfatigued BCS participant age 18 old establish firsttime diagnosis nonmetastatic ( stage 0III ) breast cancer good general health ( selfreported ) FSI severity composite score ≤ 2 Exclusion criterion nonfatigued BCS participant cancer treatment ( chemotherapy , biologic response modifier , radiation therapy , surgery ) prior 3 month &gt; 5 year ago ( endocrine therapy breast cancer allow ) enrollment hospice care severe depression ( PHQ8 ≥ 20 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Mindfulness</keyword>
	<keyword>Meditation</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Signs symptom</keyword>
</DOC>